Monday, May 16, 2022 at 5:30 pm
Register for Event

A discussion moderated by Rebecca Kim, MD, MPH.

In this session, we will have a case-based discussion on the advances in the treatment of intrahepatic cholangiocarcinoma, highlighting a neoadjuvant approach that combines systemic chemotherapy with radioablative liver-directed therapy prior to liver resection.

Attendees may claim 1.5 hours of CME credit. CME Code: 136224

Panel Members

Weldon Gilcrease, MD – Medical Oncology
Ziga Cizman, MD – Interventional Radiology
Talia Baker, MD – Transplant Surgery
Rebecca Kim, MD – Surgical Oncology